HealthNotablePartial
5.4
GLP-1 drugs show promise beyond weight loss: heart, kidney, liver, Alzheimer's
Die PresseLO·about 4 hours ago
A study identified over 1 million Americans taking GLP-1 weight-loss drugs without a documented medical reason, indicating widespread off-label or non-medical use. This raises concerns about drug safety, supply strain, and healthcare costs. The finding is based on a single study and requires corroboration.